Sakar Healthcare Quarterly Results for Trading Insights
SAKAR • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹5 Cr
QSept 2025
Sakar Healthcare Quarterly Results Key Highlights
- Revenue of ₹59 Cr in Sept 2025 (+18.0% vs Mar 2025, +37.2% vs Sept 2024)
- Net Profit of ₹5 Cr in Sept 2025 (-16.7% vs Mar 2025, +0.0% vs Sept 2024)
- EBITDA of ₹13 Cr in Sept 2025 (-18.8% vs Mar 2025)
- Operating Margin of 20.0% in Sept 2025 (-11.0pp vs Mar 2025)
- Earnings Per Share of ₹2.03 in Sept 2025 (-23.7% vs Mar 2025)
Sakar Healthcare Quarterly Results Analysis
| Metric | Sept 2025 | Mar 2025 | Jun 2025 | Sept 2024 | Mar 2024 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 59 | 50 | 53 | 43 | 44 | 18.0% | 37.2% |
| Net Profit (₹ Cr) | 5 | 6 | 5 | 5 | 3 | - | - |
| EBITDA (₹ Cr) | 13 | 16 | 13 | 12 | 12 | - | - |
| EPS (₹) | 2.03 | 2.66 | 2.11 | 2.17 | 1.46 | - | - |
| Operating Margin (%) | 20.0% | 31.0% | 24.0% | 27.0% | 25.0% | - | - |
Sakar Healthcare Share Price Trend Around Quarterly Results
Visualize Sakar Healthcare's 1-year price movement across quarterly results — ideal for logging trades in Sakar Healthcare share price
chart using Tickjournal. All values in ₹.
Related Pages for Sakar Healthcare
Additional stock information and data for SAKAR
Revenue Trend (₹ Cr)
Sept 2024
43
Jun 2025
53
Mar 2025
50
Sept 2025
59
Net Profit Trend (₹ Cr)
Sept 2024
5
Jun 2025
5
Mar 2025
6
Sept 2025
5
Operating Margin Trend (%)
Sept 2024
27.0%
Jun 2025
24.0%
Mar 2025
31.0%
Sept 2025
20.0%
Sector Competitors - Quarterly Performance Comparison
Comparing Sakar Healthcare quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹422,330.94 Cr | 1760.2 | 14,875 | 3,125 | +10.8% | - | 21.0% | 135.4 |
|
Divis Laboratories
Sept 2025 |
₹176,337.50 Cr | 6642.5 | 2,860 | 689 | +7.1% | - | 24.1% | 255.8 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹136,522.12 Cr | 3936.8 | 3,219 | 591 | +11.3% | - | 18.4% | 224.4 |
|
Cipla
Sept 2025 |
₹121,238.47 Cr | 1530.8 | 7,716 | 1,353 | +12.0% | - | 17.5% | 91.5 |
|
Dr Reddys Laborator…
Sept 2025 |
₹104,829.57 Cr | 1256.2 | 9,135 | 1,337 | +1.1% | - | 14.6% | 77.6 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores